RIGVIR holding receives LIAA funding for research in personalized medicine

RIGVIR holding company SIA "Latima" has received a grant of EUR 25 000 granted by the Investment and Development Agency of Latvia (LIAA) for the research into personalized medicine.

This project is highly valued by the state and the EU as it will make an important contribution to early cancer diagnosis and further increase the effectiveness of virotherapy.

Jumeirah Lake Towers
Swiss Tower, office 204
P.O. Box 309073, Dubai, UAE

© 2020 International Virotherapy Center Limited. All Rights Reserved